Weng, Z.-K.; Lin, T.-H.; Chang, K.-H.; Chiu, Y.-J.; Lin, C.-H.; Tseng, P.-H.; Sun, Y.-C.; Lin, W.; Lee-Chen, G.-J.; Chen, C.-M.
Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy. Biomolecules 2023, 13, 219.
https://doi.org/10.3390/biom13020219
AMA Style
Weng Z-K, Lin T-H, Chang K-H, Chiu Y-J, Lin C-H, Tseng P-H, Sun Y-C, Lin W, Lee-Chen G-J, Chen C-M.
Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy. Biomolecules. 2023; 13(2):219.
https://doi.org/10.3390/biom13020219
Chicago/Turabian Style
Weng, Zheng-Kui, Te-Hsien Lin, Kuo-Hsuan Chang, Ya-Jen Chiu, Chih-Hsin Lin, Pei-Hsuan Tseng, Ying-Chieh Sun, Wenwei Lin, Guey-Jen Lee-Chen, and Chiung-Mei Chen.
2023. "Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy" Biomolecules 13, no. 2: 219.
https://doi.org/10.3390/biom13020219
APA Style
Weng, Z.-K., Lin, T.-H., Chang, K.-H., Chiu, Y.-J., Lin, C.-H., Tseng, P.-H., Sun, Y.-C., Lin, W., Lee-Chen, G.-J., & Chen, C.-M.
(2023). Using ΔK280 TauRD Folding Reporter Cells to Screen TRKB Agonists as Alzheimer’s Disease Treatment Strategy. Biomolecules, 13(2), 219.
https://doi.org/10.3390/biom13020219
